Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
HIV Medicine|July 28, 2021
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohortMassimiliano Fabbiani, Barbara Rossetti, Arturo Ciccullo, et al.
Scientific Reports|February 11, 2016
Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenesElisa Viciani, Francesca Montagnani, Simona Tavarini, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus InfectionBarbara Rossetti, Valentina Borgo, Arianna Emiliozzi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 19, 2025
Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literatureGabriele Giuliano, Arianna Lippi, Margherita Sambo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line TherapyMassimiliano Fabbiani, Alberto Borghetti, Nicola Squillace, et al.
Nature|October 20, 2021
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variantsEmanuele Andreano, Ida Paciello, Giulia Piccini, et al.
Ebiomedicine|February 5, 2025
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesAnnalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
Plos One|November 18, 2020
Clinical and molecular characterization of COVID-19 hospitalized patientsElisa Benetti, Annarita Giliberti, Arianna Emiliozzi, et al.
Infection|February 7, 2024
In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National RegistrySilvano Esposito, Pasquale Pagliano, Giuseppe De Simone, et al.
Le Infezioni in Medicina|June 1, 2021
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019Barbara Rossetti, Lorenzo Paglicci, Velia C Di Maio, et al.
Pageof 8